Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)

China · Delayed Price · Currency is CNY

23.90

+1.03 (4.50%)

Nov 5, 2026, 3:00 PM CST

SHA:688399 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	310.43	339.05	349.61	403.18	5,535	2,839
Revenue Growth	-8.44%	-3.02%	-13.29%	-92.72%	94.95%	63.19%
Gross Profit	171.27	190.08	201.97	149.24	3,155	1,959
Operating Income	-57.6	-76.63	-68.95	-384.28	2,173	1,311
Net Income	-25.28	-41.08	-2	-373.81	1,828	1,193
Earnings Per Share	-0.18	-0.33	-0.01	-2.91	14.23	9.30
EPS Growth	-	-	-	-	53.14%	45.64%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Diagnostic Reagent	293.23
Diagnostic Instruments	13.53
Testing Services	6.1
Other	0.02
Total	312.87

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,666	1,580	1,979	2,464	2,807	1,911
Total Debt	543.11	377.09	240.55	173.46	103.79	164.23
Net Cash (Debt)	1,122	1,203	1,738	2,291	2,703	1,747
Net Cash Growth	-6.33%	-30.79%	-24.11%	-15.26%	54.77%	25.93%
Net Cash Per Share	8.02	9.70	11.72	17.85	21.05	13.61

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-12.59	30.34	145.93	-113.14	1,965	985.52
Capital Expenditures	-75.97	-64.45	-62.86	-111.34	-350.74	-303.62
Free Cash Flow	-88.57	-34.11	83.06	-224.48	1,614	681.91
Free Cash Flow Growth	-	-	-	-	136.71%	-14.90%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	55.17%	56.06%	57.77%	37.02%	56.99%	69.01%
Operating Margin	-18.56%	-22.60%	-19.72%	-95.31%	39.26%	46.16%
Pretax Margin	-1.55%	-9.46%	1.20%	-93.18%	38.64%	49.02%
Profit Margin	-8.14%	-12.12%	-0.57%	-92.72%	33.03%	42.03%
FCF Margin	-28.53%	-10.06%	23.76%	-55.68%	29.16%	24.02%

Dividends

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	2.297	-	-	-	4.565
Dividend Per Share Growth	-	-	-	-	42.86%
Dividend Yield	4.96%	-	-	-	7.27%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	2.81	6.76
P/FCF Ratio	-	-	44.86	-	3.19	11.82
PS Ratio	9.56	16.95	10.66	7.93	0.93	2.84